EGRX stock
Eagle Pharmaceuticals Inc (EGRX) institutional holders · rev $316.6M
No 13F filings for quarters ended 2026-06-30 or later list Eagle Pharmaceuticals Inc yet.
No current-quarter 13F holders on file for EGRX yet.
These 13F holders as JSON? API free 100/dayEGRX institutional holders FAQ
What is EGRX's latest revenue?
Latest cached Eagle Pharmaceuticals Inc (EGRX) revenue for Dec 31, 2022 was $316.6M. Statements: https://lician.com/financials/egrx
Not investment advice. Figures as filed or reported, not a live feed.